Dialogue between estrogen receptor and E2F signaling pathways: The transcriptional coregulator RIP140 at the crossroads

Estrogen receptors and E2F transcription factors are the key players of two nuclear signaling pathways which exert a major role in oncogenesis, particularly in the mammary gland. Different levels of dialogue between these two pathways have been deciphered and deregulation of the E2F pathway has been shown to impact the response of breast cancer cells to endocrine therapies. The present review focuses on the transcriptional coregulator RIP140/NRIP1 which is involved in several regulatory feed-back loops and inhibitory cross-talks between different nuclear signaling pathways. RIP140 regulates the transactivation potential of estrogen receptors and E2Fs and is also a direct transcriptional target of these transcription factors. Published data highlight the complex regulation of RIP140 expression at the transcriptional level and its potential role in transcription cross-talks. Indeed, a subtle regulation of RIP140 expression levels has important consequences on other transcription networks targeted by this coregulator. Another level of regulation implies titration mechanisms by which activation of a pathway leads to sequestration of the RIP140 protein and thus impinges other gene regulatory circuitries. Altogether, RIP140 occupies a place of choice in the dialogue between nuclear receptors and E2Fs, which could be highly relevant in various human pathologies such as cancer or metabolic diseases.

PDF) From molecular action to physiological outputs: Peroxisome

PDF) The RIP140 gene is a transcriptional target of E2F1

Cytoplasmic Receptor-Interacting Protein 140 (RIP140) interacts with perilipin to regulate lipolysis

Mechanisms and significance of nuclear receptor auto- and cross

Estrogen Signaling Based Current and Potential Therapies Against

Stéphan Jalaguier's research works Institut de Recherche en Cancerologie de Montpellier, Montpellier and other places

Patrick AUGEREAU, Institut de Recherche en Cancerologie de Montpellier, Montpellier, U896

The emerging role of the transcriptional coregulator RIP140 in

In vitro interaction between Rb and NGFI-B, and between Rb and SRC-2.

Stéphan Jalaguier's research works Institut de Recherche en Cancerologie de Montpellier, Montpellier and other places

Marion LAPIERRE, Researcher, PhD, Institut de Recherche en Cancerologie de Montpellier, Montpellier, Signalisation Nucléaire et Cancer (SNeC)

Dialogue between estrogen receptor and E2F signaling pathways: The

Free Download Dialogue Between Estrogen Receptor And E2F Signaling

Cancers, Free Full-Text